Showing 82,601 - 82,620 results of 123,999 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 82601

    Table1_Placental treatment with insulin-like growth factor 1 via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/decidua.DOCX by Baylea N. Davenport (14324355)

    Published 2023
    “…Additionally, there are no effective in utero treatment options for FGR. We have developed a nanoparticle to deliver human insulin-like 1 growth factor (hIGF-1) in a trophoblast-specific manner which results in increased expression of hIGF-1. …”
  2. 82602

    Baseline characteristics for pneumonia. by Mathias Aagaard Christensen (19139443)

    Published 2024
    “…</p><p>Results</p><p>Models were generated for atrial fibrillation, venous thromboembolism and pneumonia as genetics only, clinical features only and a combined model. For venous thromboembolism, the ROC-AUCs were 60.1% [59.6%-60.4%], 63.4% [63.2%-63.4%] and 66.6% [66.2%-66.9%] for the linear models and 51.5% [49.4%-53.4%], 63.2% [61.2%-65.0%] and 62.6% [60.7%-64.5%] for the deep learning SNP, clinical and combined models, respectively. …”
  3. 82603

    Complexes with Redox-Active Ligands: Synthesis, Structure, and Electrochemical and Photophysical Behavior of the Ru(II) Complex with TTF-Annulated Phenanthroline by Lawrence K. Keniley (1936060)

    Published 2013
    “…Ru­(II) complexes with chelating ligands, 4′,5′-ethylene­dithio­tetra­thiafulvenyl­[4,5-<i>f</i>]­[1,10]­phenan­throline (<b>L1</b>), 1,3-dithiole-2-thiono­[4,5-<i>f</i>]­[1,10]­phenanthroline (<b>L2</b>), and 1,3-dithiole-2-ono­[4,5-<i>f</i>]­[1,10]­phenanthroline (<b>L3</b>), have been prepared and their structural, electrochemical, and photophysical properties investigated. …”
  4. 82604

    Supplemental material for Fig 2. by Hannah Gordon (8729760)

    Published 2024
    “…(h) Quantification of the abundance of 561-Eos<sup>+</sup> microglia in <i>Tg(pu1</i>:<i>Eos)</i> animals that had all microglia photoconverted a 3 dpf and then quantified at 6 dpf. Each data point with connect line represent a single animal. …”
  5. 82605

    Complementary conditioning measures in healthy subjects. by Gabriela Ribeiro (4748373)

    Published 2024
    “…<b>(F) Intake</b> volumes were higher for CS<sup>+</sup> than CS<sup>-</sup> (F<sub>(1,102)</sub> = 5.5, <i>P</i> = 0.02), and decreased across conditioning days (F<sub>(1,102)</sub> = 8.1, <i>P</i> = 0.005; Interaction: F<sub>(1,102)</sub> = 0.5, <i>P</i> = 0.5; repeated-measures 2-way ANOVA). …”
  6. 82606

    Respiratory Exchange Ratio (RER) in ADKD and ADOX WT and OB mice. by Kazuhisa Watanabe (426012)

    Published 2013
    “…Data shown are mean ± SEM (8 mice per group) and run in a TSE systems indirect calorimeter for 48 hr. …”
  7. 82607

    General Health Questionnaire (GHQ12): new evidence of construct validity by Tulio Augusto Andrade Oliveira (14728698)

    Published 2023
    “…The study included 1,085 physicians with a mean age of 45.7 (SD = 10.6), mostly male (61.5%), married (72.6%) and Catholic (59.2%). …”
  8. 82608

    Reduced production of white blood cells (WBC) in <i>Iqgap2</i><sup><i>-/-</i></sup> mice. by Amr M. Ghaleb (668342)

    Published 2015
    “…Data are presented as the mean ± SEM. N = 3 per genotype/treatment (<b>A</b>), N = 5 per genotype/treatment (<b>B</b>), p-values indicating statistically significant differences are shown.…”
  9. 82609

    An attenuation of WP caused downregulation of MMP7 in PTEN null TNBC cells. by Nandini Dey (470883)

    Published 2013
    “…Pharmacological attenuation of beta-catenin in PTEN null MMP7 expressing TNBC cell lines, MDA-MB468 (B i) and SUM149 (B ii) following the treatment with XAV939 (B i) and sulindac sulfide (B ii) caused a decrease in MMP7 protein expression as well as an abrogation of its enzymatic activity. …”
  10. 82610

    Effects of aging and exposure to high-fat diet on spatial strategy use in the Barnes maze. by James P. Kesby (811190)

    Published 2015
    “…<p>Spatial (<b>A,D,G</b>), serial (<b>B,E,H</b>) and mixed/random (<b>C,F,I</b>) strategy use by adult and aged mice on control diet (CD) and high-fat diet (HFD) on the Barnes maze acquisition days (a1-a5), retention day (Ret) and reversal learning days (Rv1-Rv2). …”
  11. 82611

    CO suppression of LPS-induced IL-1β transcription, mRNA expression, and protein production. by Maneesha Chhikara (256460)

    Published 2009
    “…<p>(A) Nuclear run-on assays in THP-1 cells (2×10<sup>7</sup>) showed that CO represses IL-1β transcription by almost 98% within 30 min of LPS stimulation (p = 0.001) and the effect decreased to 67% at 60 min (p = 0.01). …”
  12. 82612

    DHA treatment and genotype modulate active properties of EC deep layer neurons. by Dany Arsenault (229311)

    Published 2011
    “…<p>(A, B) Examples of recording trace showing voltage response to a 3-s depolarizing current at the excitation threshold (top trace) and 80±5 pA above the rheobase (bottom trace) from the same neuron of each group. …”
  13. 82613

    Classification accuracy under fixed iterations. by Alexander Tscshantz (16734185)

    Published 2023
    “…The classification accuracy of standard predictive coding slowly decreases over batches, illustrating a common pathology observed in these simulations. …”
  14. 82614

    <i>LGG</i> protects against intestinal injury induced by PAF and LPS. by Julie Mirpuri (109883)

    Published 2012
    “…PAF/LPS-treated mice that were pre-treated with <i>LGG</i> had lower intestinal injury scores than those pre-treated with vehicle alone (A), representative images are shown. Inflammatory cytokines MIP-2 and TNF-α were also measured by qRT-PCR after PAF/LPS and found to be decreased in the mice pre-treated with <i>LGG</i> (B). …”
  15. 82615

    Effects of vaccination on HSA during dose reduction and reinstatement. by Michael D. Raleigh (678771)

    Published 2014
    “…<p>Median total heroin infusions in rats that acquired HSA and completed the dose-reduction protocol (left panel). Rats were trained at a heroin unit dose of 0.06 mg/kg/inf. The heroin dose was sequentially decreased every 5 days to 0.03, 0.01, 0.003 and 0 mg/kg to obtain a dose-response curve. …”
  16. 82616

    Supplementary Material for: Quantification of Posterior Risk Related to Intrapartum FIGO 2015 Criteria for Cardiotocography in the Second Stage of Labor by Cavoretto P.I. (10046660)

    Published 2021
    “…Occurrence of FIGO 2015 pathological CTG patterns showed a decreasing impact from bradycardia >10 min to decelerations >5 min, recurrent later or prolonged decelerations >30 min, and nonpathological CTG.…”
  17. 82617

    Data_Sheet_1_Mechanical Determinants of the U-Shaped Speed-Energy Cost of Running Relationship.docx by Apolline Carrard (6093833)

    Published 2018
    “…<p>Purpose: The aim of this study was to investigate the relationship between the energy cost of running (Cr) and speed and its mechanical determinants by comparing running in normal [100% body weight (BW)] and reduced (20% and 60% BW) gravity conditions at several speeds (2.25, 3.17, 4.08, and 5.00 m·s<sup>−1</sup>) in experienced runners.</p><p>Methods: Twelve experienced runners (24.6 ± 5.4 year) ran on an AlterG treadmill in a partially randomized order at the four running speeds and at the three gravity conditions in order to assess Cr, spatiotemporal parameters, spring-mass characteristics and elastic energy (EL) during running.…”
  18. 82618

    Temporal Variation of Soil Physical Quality under Conventional and No-Till Systems by Carlos Germán Soracco (5112683)

    Published 2018
    “…Under NT, most dynamic indicators increase from BS to V6 and decrease again at AH, whereas under CT, they follow a different trend, decreasing from BS to V6, remaining constant until R5, and increasing at AH. …”
  19. 82619

    Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer by Christian Eberhardt (315762)

    Published 2018
    “…An increase in T2 time, again greater in ePH was most pronounced on day 5: 21% for cPH vs. 41% for ePH. ADC and MTR showed a decrease on day 1: 21% for ePH vs. 13% for cPH for ADC, 15% for ePH vs. 11% for cPH for MTR. …”
  20. 82620

    Randomized clinical trials in dentistry: Risks of bias, risks of random errors, reporting quality, and methodologic quality over the years 1955–2013 by Humam Saltaji (464821)

    Published 2017
    “…Two thirds of the trials were not described as double blinded (n = 358; 66.3%), while the method of blinding was appropriate in 53% (n = 286) of the trials. We identified a significant decrease over time (1955–2013) in the proportion of trials assessed as having inadequately addressed methodological quality items (P < 0.05) in 30 out of the 40 quality criteria, or as being inadequate (at high or unclear risk of bias) in five domains of the Cochrane risk of bias tool: sequence generation, allocation concealment, incomplete outcome data, other sources of bias, and overall risk of bias.…”